BIOSCIENCE trial further confirms Orsiro as best in class
Results of the BIOSCIENCE study were announced. The independent study was intended to confirm safety and efficacy of Orsiro, the world’s first Hybrid Drug-Eluting Stent. The announcement of Orsiro’s excellent results will be published in The Lancet journal. September 01, 2014